Neuroimplant Trial Participants Demand More Rights, Fewer Restrictions

Neuroimplant Trial Participants Demand More Rights, Fewer Restrictions
Neuroimplant Trial Participants Demand More Rights, Fewer Restrictions

Neuroimplant Trial Participants Demand More Rights, Fewer Restrictions

November, 16 2026
Click to view quick news summary (Spoiler)

BCI trial participants call for fewer restrictive NDAs, better protection of neural recordings, ongoing consent and post-trial device support.

Participants in clinical trials of brain implants have called for limiting non-disclosure agreements (NDAs), enhancing the protection of brain activity data, and ensuring user support after the conclusion of studies. The BCI Pioneers Coalition presented these recommendations for neurointerface developers, scientists, and ethics committees. The document was published on November 10. It spans 13 pages and covers the entire trial process—from volunteer recruitment to device maintenance after experiments conclude.

Fewer Non-Disclosure Agreements

One of the central demands concerns the right of participants to share their experiences with neuroimplants. Developers of experimental devices may require NDAs to protect confidential information. However, the authors of the recommendations believe such agreements should not hinder reports on safety issues. The coalition is not advocating for a complete abandonment of trade secrets. Instead, it suggests limiting agreements that could prevent volunteers from reporting risks and shortcomings of the technologies.

The authors also call for a review of the informed consent procedure. Currently, participation in clinical trials involves prior familiarization with conditions and potential risks. However, circumstances may change after the device is implanted. Therefore, consent, according to coalition representatives, should remain a topic of ongoing discussion between researchers and users, rather than being confined to signing documents before surgery. Ian Burkhart, founder of the BCI Pioneers Coalition, emphasized that people with disabilities should be involved in decisions shaping the development and accessibility of neurotechnologies.

Additionally, the coalition proposes fair compensation for volunteers participating in research and recognition of their intellectual contributions to device development.

Who Owns Brain Data?

A separate set of recommendations addresses the information collected by neurointerfaces. These devices record brain electrical activity and convert signals into commands for computers, prosthetics, or other equipment. Researchers may accumulate significant volumes of neural recordings to fine-tune algorithms. However, it remains unclear who determines the conditions for storing, transmitting, and further using this data. The BCI Pioneers Coalition suggests treating neurodata as personal information of participants and providing them with more details on how it is collected and processed.

Burkhart urged for clear and revocable consent for data processing, limiting its collection and transmission to third parties, and protecting it from coercive use by employers, insurers, and government entities. Currently, modern neurointerfaces cannot arbitrarily read any human thoughts. Their capabilities depend on electrode placement, decoding algorithms, and the tasks for which the system was trained. However, even limited sets of neural signals may contain sensitive information requiring special protection.

What Happens to Implants After Trials

Another issue concerns the fate of devices after clinical trials end. An experimental neurointerface may allow a person with paralysis to control a computer, communicate, or interact with a prosthetic. However, the end of a project does not guarantee the system’s continued operation.

Its use may require regular adjustments, software updates, and technical maintenance. If researchers cease support, users risk losing acquired capabilities, even if the implant remains in the body. The BCI Pioneers Coalition proposes defining developers’ and researchers’ responsibilities for device maintenance post-trials, as well as participants’ rights to equipment and software. However, the recommendations do not guarantee lifelong access to experimental systems.

Previously, authors of an ethics study on neuroimplants recommended planning for the continued use of devices by participants who benefit from them, as well as developing contingency plans for the cessation of research or manufacturer bankruptcy. In June, researchers from the University of California, Davis, reported that a speech neurointerface helped a patient with amyotrophic lateral sclerosis transmit nearly 2 million words over 19 months.

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept